Review Artikel – SMA Schweiz – Zusammen für eine Zukunft!
Porensky P & Burghes A. 2013. Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy. Human Gene Therapy, 24(5): 489-498. doi:10.1089/hum.2012.225.
Mercuri E, Bertini E, Iannaccone S. 2012. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol., 11: 443-452.
Markowitz J, Singh, Darras B. 2012. Spinal Muscula Atrohpy: A Clinical and Research Update. Pediactric Neurology, 46: 1-12.
Fallini C, Bassell G, Rossoll W. 2012. Spinal muscular atrophy: The role of SMN in axonal mRNA regulation. Brain Research, 1462: 81-92.
Coady T and Lorson C. 2011. SMN in spinal muscular atrophy and snRNP biogenesis. Wiley interdisciplinary reviews, 2, 546-564.
Passini M and Cheng S. 2011. Prospects for the gene therapy of spinal muscular atrophy. Trends in Molecular Medicine, 17: 259-265.
Burghes A and Beattie C. 2009. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci., 10, 597-609.